Invention Application
US20050070529A1 Use of type 4 phosphodiesterase inhibitors in myocardial diseases
审中-公开
在心肌疾病中使用4型磷酸二酯酶抑制剂
- Patent Title: Use of type 4 phosphodiesterase inhibitors in myocardial diseases
- Patent Title (中): 在心肌疾病中使用4型磷酸二酯酶抑制剂
-
Application No.: US10467793Application Date: 2002-01-15
-
Publication No.: US20050070529A1Publication Date: 2005-03-31
- Inventor: Arne Sutter , Thomas Ehring , Thomas Welge , Klause Minck , Claudia Wilm , Michael Gassen , Hans-Michael Eggenweiler , Michael Wolf , Pierre Schelling , Norbert Beier , Joachim Leibrock
- Applicant: Arne Sutter , Thomas Ehring , Thomas Welge , Klause Minck , Claudia Wilm , Michael Gassen , Hans-Michael Eggenweiler , Michael Wolf , Pierre Schelling , Norbert Beier , Joachim Leibrock
- Applicant Address: DE Darmstadt 64293
- Assignee: Merk Pantent GmbH
- Current Assignee: Merk Pantent GmbH
- Current Assignee Address: DE Darmstadt 64293
- Priority: EP01102811.5 20010212; DE01119875.1 20010817
- International Application: PCT/EP02/00320 WO 20020115
- Main IPC: A61K31/50
- IPC: A61K31/50 ; A61K31/501 ; A61K31/535 ; A61K31/5395 ; A61K31/54 ; A61K31/549 ; A61P9/00 ; A61P29/00 ; A61P37/02
Abstract:
The invention relates to the use of type 4 phosphodiesterase inhibitors to treat myocardial diseases.
Information query
